News from the Children's Hospital of Philadelphia
Initial results from the first-ever international clinical trial of an experimental T-cell therapy for pediatric leukemia, led by Stephen Grupp, MD, PhD, have been published. It’s expected that the treatment will be filed for U.S. Food and Drug Administration approval in early 2017, and later in 2017 for European regulatory approval.
View additional CHOP Department of International Medicine Updates here.
Fifteen months ago, 15-year-old Emma Collins was dying of leukemia. With no other option, her parents took her from their home in rural Canada for a last-ditch experimental treatment at Children's Hospital of Philadelphia, a choice that families from Croatia and... Full Story (via philly.com)